You are using an outdated browser. For a faster, safer browsing experience, upgrade for free today.

Medical Care

Global Breast Cancer Monoclonal Antibodies Market Analysis 2016-2020 and Forecast 2021-2026

Snapshot
The global Breast Cancer Monoclonal Antibodies market size is estimated at xxx million USD with a CAGR xx% from 2016-2020 and is expected to reach xxx Million USD in 2021 with a CAGR xx% from 2021 to 2026. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Breast Cancer Monoclonal Antibodies by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.
Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
Naked mAbs
Conjugated mAbs
Company Coverage (Company Profile, Sales Revenue, Price, Gross Margin, Main Products etc.):
F. Hoffmann-La Roche
Amgen
Mylan
Pfizer
Merck
Novartis
GlaxoSmithKline
AstraZeneca
Eisai
Boehringer Ingelheim
Puma Biotechnology
Teva Pharmaceuticals
Sun Pharmaceutical Industries
Watson Pharmaceuticals
Allergan
Synta Pharmaceuticals
Chugai Pharmaceutical
Daiichi Sankyo
Array BioPharma
Biocad
Seattle Genetics
Galena Biopharma
Eddingpharm
Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):
Hospitals
Clinics
Retail Pharmacies
Region Coverage (Regional Production, Demand & Forecast by Countries etc.):
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)
Table of Contents
1 Industry Overview
1.1 Breast Cancer Monoclonal Antibodies Industry
Figure Breast Cancer Monoclonal Antibodies Industry Chain Structure
1.1.1 Overview
1.1.2 Development of Breast Cancer Monoclonal Antibodies
1.2 Market Segment
1.2.1 Upstream
Table Upstream Segment of Breast Cancer Monoclonal Antibodies
1.2.2 Downstream
Table Application Segment of Breast Cancer Monoclonal Antibodies
Table Global Breast Cancer Monoclonal Antibodies Market 2016-2026, by Application, in USD Million
1.2.3 COVID-19 Impact
1.3 Cost Analysis
2 Industry Environment (PEST Analysis)
2.1 Policy
2.2 Economics
2.3 Sociology
2.4 Technology
3 Breast Cancer Monoclonal Antibodies Market by Type
3.1 By Type
3.1.1 Naked mAbs
Table Major Company List of Naked mAbs
3.1.2 Conjugated mAbs
Table Major Company List of Conjugated mAbs
3.2 Market Size
Table Global Breast Cancer Monoclonal Antibodies Market 2016-2020, by Type, in USD Million
Figure Global Breast Cancer Monoclonal Antibodies Market Growth 2016-2020, by Type, in USD Million
Table Global Breast Cancer Monoclonal Antibodies Market 2016-2020, by Type, in Volume
Figure Global Breast Cancer Monoclonal Antibodies Market Growth 2016-2020, by Type, in Volume
3.3 Market Forecast
Table Global Breast Cancer Monoclonal Antibodies Market Forecast 2021-2026, by Type, in USD Million
Table Global Breast Cancer Monoclonal Antibodies Market Forecast 2021-2026, by Type, in Volume
4 Major Companies List
4.1 F. Hoffmann-La Roche (Company Profile, Sales Data etc.)
4.1.1 F. Hoffmann-La Roche Profile
Table F. Hoffmann-La Roche Overview List
4.1.2 F. Hoffmann-La Roche Products & Services
4.1.3 F. Hoffmann-La Roche Business Operation Conditions
Table Business Operation of F. Hoffmann-La Roche (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.2 Amgen (Company Profile, Sales Data etc.)
4.2.1 Amgen Profile
Table Amgen Overview List
4.2.2 Amgen Products & Services
4.2.3 Amgen Business Operation Conditions
Table Business Operation of Amgen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.3 Mylan (Company Profile, Sales Data etc.)
4.3.1 Mylan Profile
Table Mylan Overview List
4.3.2 Mylan Products & Services
4.3.3 Mylan Business Operation Conditions
Table Business Operation of Mylan (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.4 Pfizer (Company Profile, Sales Data etc.)
4.4.1 Pfizer Profile
Table Pfizer Overview List
4.4.2 Pfizer Products & Services
4.4.3 Pfizer Business Operation Conditions
Table Business Operation of Pfizer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.5 Merck (Company Profile, Sales Data etc.)
4.5.1 Merck Profile
Table Merck Overview List
4.5.2 Merck Products & Services
4.5.3 Merck Business Operation Conditions
Table Business Operation of Merck (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.6 Novartis (Company Profile, Sales Data etc.)
4.6.1 Novartis Profile
Table Novartis Overview List
4.6.2 Novartis Products & Services
4.6.3 Novartis Business Operation Conditions
Table Business Operation of Novartis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.7 GlaxoSmithKline (Company Profile, Sales Data etc.)
4.7.1 GlaxoSmithKline Profile
Table GlaxoSmithKline Overview List
4.7.2 GlaxoSmithKline Products & Services
4.7.3 GlaxoSmithKline Business Operation Conditions
Table Business Operation of GlaxoSmithKline (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.8 AstraZeneca (Company Profile, Sales Data etc.)
4.8.1 AstraZeneca Profile
Table AstraZeneca Overview List
4.8.2 AstraZeneca Products & Services
4.8.3 AstraZeneca Business Operation Conditions
Table Business Operation of AstraZeneca (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.9 Eisai (Company Profile, Sales Data etc.)
4.9.1 Eisai Profile
Table Eisai Overview List
4.9.2 Eisai Products & Services
4.9.3 Eisai Business Operation Conditions
Table Business Operation of Eisai (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.10 Boehringer Ingelheim (Company Profile, Sales Data etc.)
4.10.1 Boehringer Ingelheim Profile
Table Boehringer Ingelheim Overview List
4.10.2 Boehringer Ingelheim Products & Services
4.10.3 Boehringer Ingelheim Business Operation Conditions
Table Business Operation of Boehringer Ingelheim (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.11 Puma Biotechnology (Company Profile, Sales Data etc.)
4.11.1 Puma Biotechnology Profile
Table Puma Biotechnology Overview List
4.11.2 Puma Biotechnology Products & Services
4.11.3 Puma Biotechnology Business Operation Conditions
Table Business Operation of Puma Biotechnology (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.12 Teva Pharmaceuticals (Company Profile, Sales Data etc.)
4.12.1 Teva Pharmaceuticals Profile
Table Teva Pharmaceuticals Overview List
4.12.2 Teva Pharmaceuticals Products & Services
4.12.3 Teva Pharmaceuticals Business Operation Conditions
Table Business Operation of Teva Pharmaceuticals (Sales Revenue, Cost, Gross Margin)
4.13 Sun Pharmaceutical Industries (Company Profile, Sales Data etc.)
4.13.1 Sun Pharmaceutical Industries Profile
Table Sun Pharmaceutical Industries Overview List
4.13.2 Sun Pharmaceutical Industries Products & Services
4.13.3 Sun Pharmaceutical Industries Business Operation Conditions
Table Business Operation of Sun Pharmaceutical Industries (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.14 Watson Pharmaceuticals (Company Profile, Sales Data etc.)
4.14.1 Watson Pharmaceuticals Profile
Table Watson Pharmaceuticals Overview List
4.14.2 Watson Pharmaceuticals Products & Services
4.14.3 Watson Pharmaceuticals Business Operation Conditions
Table Business Operation of Watson Pharmaceuticals (Sales Revenue, Cost, Gross Margin)
4.15 Allergan (Company Profile, Sales Data etc.)
4.15.1 Allergan Profile
Table Allergan Overview List
4.15.2 Allergan Products & Services
4.15.3 Allergan Business Operation Conditions
Table Business Operation of Allergan (Sales Revenue, Cost, Gross Margin)
4.16 Synta Pharmaceuticals (Company Profile, Sales Data etc.)
4.16.1 Synta Pharmaceuticals Profile
Table Synta Pharmaceuticals Overview List
4.16.2 Synta Pharmaceuticals Products & Services
4.16.3 Synta Pharmaceuticals Business Operation Conditions
Table Business Operation of Synta Pharmaceuticals (Sales Revenue, Cost, Gross Margin)
4.17 Chugai Pharmaceutical (Company Profile, Sales Data etc.)
4.17.1 Chugai Pharmaceutical Profile
Table Chugai Pharmaceutical Overview List
4.17.2 Chugai Pharmaceutical Products & Services
4.17.3 Chugai Pharmaceutical Business Operation Conditions
Table Business Operation of Chugai Pharmaceutical (Sales Revenue, Cost, Gross Margin)
4.18 Daiichi Sankyo (Company Profile, Sales Data etc.)
4.18.1 Daiichi Sankyo Profile
Table Daiichi Sankyo Overview List
4.18.2 Daiichi Sankyo Products & Services
4.18.3 Daiichi Sankyo Business Operation Conditions
Table Business Operation of Daiichi Sankyo (Sales Revenue, Cost, Gross Margin)
4.19 Array BioPharma (Company Profile, Sales Data etc.)
4.19.1 Array BioPharma Profile
Table Array BioPharma Overview List
4.19.2 Array BioPharma Products & Services
4.19.3 Array BioPharma Business Operation Conditions
Table Business Operation of Array BioPharma (Sales Revenue, Cost, Gross Margin)
4.20 Biocad (Company Profile, Sales Data etc.)
4.20.1 Biocad Profile
Table Biocad Overview List
4.20.2 Biocad Products & Services
4.20.3 Biocad Business Operation Conditions
Table Business Operation of Biocad (Sales Revenue, Cost, Gross Margin)
4.21 Seattle Genetics (Company Profile, Sales Data etc.)
4.21.1 Seattle Genetics Profile
Table Seattle Genetics Overview List
4.21.2 Seattle Genetics Products & Services
4.21.3 Seattle Genetics Business Operation Conditions
Table Business Operation of Seattle Genetics (Sales Revenue, Cost, Gross Margin)
4.22 Galena Biopharma (Company Profile, Sales Data etc.)
4.22.1 Galena Biopharma Profile
Table Galena Biopharma Overview List
4.22.2 Galena Biopharma Products & Services
4.22.3 Galena Biopharma Business Operation Conditions
Table Business Operation of Galena Biopharma (Sales Revenue, Cost, Gross Margin)
4.23 Eddingpharm (Company Profile, Sales Data etc.)
4.23.1 Eddingpharm Profile
Table Eddingpharm Overview List
4.23.2 Eddingpharm Products & Services
4.23.3 Eddingpharm Business Operation Conditions
Table Business Operation of Eddingpharm (Sales Revenue, Cost, Gross Margin)
5 Market Competition
5.1 Company Competition
Table Global Breast Cancer Monoclonal Antibodies Sales Revenue 2016-2020, by Company, in USD Million
Table Global Breast Cancer Monoclonal Antibodies Sales Revenue Share 2016-2020, by Company, in USD Million
Figure Global Breast Cancer Monoclonal Antibodies Sales Revenue Share in 2020, by Company, in USD Million
Table Global Breast Cancer Monoclonal Antibodies Sales Volume 2016-2020, by Company, in Volume
Table Global Breast Cancer Monoclonal Antibodies Sales Volume Share 2016-2020, by Company, in Volume
Figure Global Breast Cancer Monoclonal Antibodies Sales Volume Share in 2020, by Company, in Volume
5.2 Regional Market by Company
Figure North America Breast Cancer Monoclonal Antibodies Market Concentration, in 2020
Figure Europe Breast Cancer Monoclonal Antibodies Market Market Concentration, in 2020
Figure Asia-Pacific Breast Cancer Monoclonal Antibodies MMarket Concentration, in 2020
Figure South America Breast Cancer Monoclonal Antibodies Market Concentration, in 2020
Figure Middle East & Africa Breast Cancer Monoclonal Antibodies Market Concentration, in 2020
6 Demand by End Market
6.1 Demand Situation
6.1.1 Demand in Hospitals
Figure Breast Cancer Monoclonal Antibodies Demand in Hospitals, 2016-2020, in USD Million
Figure Breast Cancer Monoclonal Antibodies Demand in Hospitals, 2016-2020, in Volume
6.1.2 Demand in Clinics
Figure Breast Cancer Monoclonal Antibodies Demand in Clinics, 2016-2020, in USD Million
Figure Breast Cancer Monoclonal Antibodies Demand in Clinics, 2016-2020, in Volume
6.1.3 Demand in Retail Pharmacies
Figure Breast Cancer Monoclonal Antibodies Demand in Retail Pharmacies, 2016-2020, in USD Million
Figure Breast Cancer Monoclonal Antibodies Demand in Retail Pharmacies, 2016-2020, in Volume
6.2 Regional Demand Comparison
Table Regional Demand Comparison List
Table Major Application in Different Regions
6.3 Demand Forecast
Table Breast Cancer Monoclonal Antibodies Demand Forecast 2021-2026, by Application, in USD Million
Figure Breast Cancer Monoclonal Antibodies Market Growth 2021-2026, by Application, in USD Million
Figure Breast Cancer Monoclonal Antibodies Market Share in 2026, by Application, in USD Million
Table Breast Cancer Monoclonal Antibodies Demand Forecast 2021-2026, by Application, in Volume
Table Breast Cancer Monoclonal Antibodies Market Growth 2021-2026, by Application, in Volume
Table Breast Cancer Monoclonal Antibodies Market Share in 2026, by Application, in Volume
6.4 Impact of the COVID-19 on the Demand
7 Region Operation
7.1 Regional Production
Table Breast Cancer Monoclonal Antibodies Production 2016-2020, by Region, in USD Million
Table Breast Cancer Monoclonal Antibodies Production 2016-2020, by Region, in Volume
7.2 Regional Market
Table Global Breast Cancer Monoclonal Antibodies Market 2016-2020, by Region, in USD Million
Table Global Breast Cancer Monoclonal Antibodies Market Share 2016-2020, by Region, in USD Million
Table Global Breast Cancer Monoclonal Antibodies Market 2016-2020, by Region, in Volume
Table Global Breast Cancer Monoclonal Antibodies Market Share 2016-2020, by Region, in Volume
7.3 by Region
7.3.1 North America
7.3.1.1 Overview
Figure North America Breast Cancer Monoclonal Antibodies Market Size and Growth 2016-2020, in USD Million
Figure North America Breast Cancer Monoclonal Antibodies Market Size and Growth 2016-2020, in Volume
7.3.1.2 by Country (U.S., Canada, Mexico)
Table North America Breast Cancer Monoclonal Antibodies Market Size 2016-2020, by Country, in USD Million
Table North America Breast Cancer Monoclonal Antibodies Market Size 2016-2020, by Country, in Volume
7.3.2 Europe
7.3.2.1 Overview
Figure Europe Breast Cancer Monoclonal Antibodies Market Size and Growth 2016-2020, in USD Million
Figure Europe Breast Cancer Monoclonal Antibodies Market Size and Growth 2016-2020, in Volume
7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)
Table Europe Breast Cancer Monoclonal Antibodies Market Size 2016-2020, by Country, in USD Million
Table Europe Breast Cancer Monoclonal Antibodies Market Size 2016-2020, by Country, in Volume
7.3.3 Asia-Pacific
7.3.3.1 Overview
Figure Asia-Pacific Breast Cancer Monoclonal Antibodies Market Size and Growth 2016-2020, in USD Million
Figure Asia-Pacific Breast Cancer Monoclonal Antibodies Market Size and Growth 2016-2020, in Volume
7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)
Table Asia-Pacific Breast Cancer Monoclonal Antibodies Market Size 2016-2020, by Country, in USD Million
Table Asia-Pacific Breast Cancer Monoclonal Antibodies Market Size 2016-2020, by Country, in Volume
7.3.4 South America
7.3.4.1 Overview
Figure South America Breast Cancer Monoclonal Antibodies Market Size and Growth 2016-2020, in USD Million
Figure South America Breast Cancer Monoclonal Antibodies Market Size and Growth 2016-2020, in Volume
7.3.4.2 by Country (Brazil, Argentina etc.)
Table South America Breast Cancer Monoclonal Antibodies Market Size 2016-2020, by Country, in USD Million
Table South America Breast Cancer Monoclonal Antibodies Market Size 2016-2020, by Country, in Volume
7.3.5 Middle East & Africa
7.3.5.1 Overview
Figure Middle East & Africa Breast Cancer Monoclonal Antibodies Market Size and Growth 2016-2020, in USD Million
Figure Middle East & Africa Breast Cancer Monoclonal Antibodies Market Size and Growth 2016-2020, in Volume
7.3.5.2 by Country (Saudi Arabia, South Africa etc.)
Table Middle East & Africa Breast Cancer Monoclonal Antibodies Market Size 2016-2020, by Country, in USD Million
Table Middle East & Africa Breast Cancer Monoclonal Antibodies Market Size 2016-2020, by Country, in Volume
7.4 Regional Import & Export
7.5 Regional Forecast
Table Breast Cancer Monoclonal Antibodies Market Forecast 2021-2026, by Region, in USD Million
Table Breast Cancer Monoclonal Antibodies Market Forecast 2021-2026, by Region, in Volume
8 Marketing & Price
8.1 Price and Margin
8.1.1 Price Trends
8.1.2 Factors of Price Change
Table Price Factors List
8.1.3 Manufacturers Gross Margin Analysis
8.2 Marketing Channel
Figure Marketing Channels Overview
9 Research Conclusion
  • FORMAT: PDF
  • PUBLISHED DATE: Apr, 2021
  • NO OF PAGES: 125